HIPREX

This brand name is authorized in Australia, Ecuador, Estonia, Finland, Mexico, New Zealand, United Kingdom, United States

Active ingredients

The drug HIPREX contains one active pharmaceutical ingredient (API):

1 Methenamine UNII M329791L57 - METHENAMINE HIPPURATE

Methenamine is a urinary antibacterial agent with a wide antibacterial spectrum covering both gram-positive and gram-negative organisms. Urinary antibacterial activity can be shown within 30 minutes of administration. Read about Methenamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HIPREX Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX05	Methenamine	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 3124K
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1076-MEE-0615
Country: EE	Ravimiamet	Identifier(s): 1879599
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 005769, 124339
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 36920, 398581
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 61866
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1248
Country: US	FDA, National Drug Code	Identifier(s): 30698-277